• Kit Lu, Mok-Chung Jennifer Cheng, Xiaoying Ge, Ann Berger, Dihua Xu, Gregory J Kato, and Caterina P Minniti.
• *Hematology Branch ‡Office of Biostatistics Research §Sickle Cell Vascular Disease Section, Hematology Branch, National Heart, Lung, and Blood Institute †Pain and Palliative Care, Clinical Center, National Institutes of Health, Bethesda, MD.
• Clin J Pain. 2014 Sep 1; 30 (9): 825830825-30.

ObjectivesThis retrospective study describes the use of acupuncture for adult sickle cell patients in a single institution.Materials And MethodsWe identified 47 sickle cell disease patients referred for acupuncture at the National Institutes of Health between January 2005 and September 2011. All patients were enrolled in a Study of the Natural History of sickle cell disease and signed consent. We reviewed patient demographics, location of acupuncture treatment sessions (inpatient vs. outpatient), number of sessions received, sites of pain, patient pain reporting, and the use of other complementary therapies.ResultsOf the 47 patients (60% women, median age 36 y) referred for acupuncture, 42 had homozygous SS disease (89%) and 5 had SC disease (11%). Over half of the patients (51%) reported >3 sites of pain. Only 24 patients (51%) underwent acupuncture treatment. Of those who elected not to receive acupuncture, a majority (87%) accepted some other forms of complementary therapies. Nine patients underwent only inpatient acupuncture for acute vaso-occlusive crisis. Eleven patients received only outpatient acupuncture treatment for chronic pain, and 4 patients received both inpatient and outpatient treatments. For the patients who received inpatient acupuncture treatment for acute vaso-occlusive crisis, there was a significant reduction of reported pain score immediately after acupuncture treatment with an average pain reduction of 2.1 points on the numeric pain scale (P<0.0001). Excluding the 2 outliers, 75% of patients (n=13) in the outpatient setting described their pain as improved compared with prior session.DiscussionTo our knowledge, this is the largest retrospective review of acupuncture use in the sickle cell population. This analysis describes the use of acupuncture and raises the possibility of its use as an adjuvant for pain management in this population. Future clinical trials are needed to evaluate acupuncture's efficacy and effectiveness for pain management in different treatment settings and for various types of pain etiologies among the sickle cell population.

22 keywords...

hide…